Clinical Trial Update: A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating the efficacy and safety of zanubrutinib in adults with primary membranous nephropathy is active but not currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: BeOne Medicines | Conditions: Primary Membranous Nephropathy | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING